Kawasaki H, Takasaki K
J Pharmacol Exp Ther. 1986 Mar;236(3):810-8.
Possible involvement of central alpha-2 adrenoceptors in the hypertensive response to i.c.v. injected clonidine was investigated in free-moving, normotensive rats. Clonidine (2-50 micrograms) injected i.c.v. produced a dose-dependent and long-lasting pressor response associated with bradycardia in conscious rats, but a long-lasting depressor response in anesthetized rats. The pressor response to clonidine (20 micrograms i.c.v.) was antagonized in a dose-dependent manner by central (i.c.v.) pretreatment with yohimbine (20-100 micrograms) and was abolished by a high dose (100 micrograms), whereas the same dose of yohimbine injected i.v. had less effect on the response. Central pretreatment with prazosin (10 and 20 micrograms) inhibited, but did not abolish, the pressor response to clonidine. However, systemic (i.v.) pretreatment with the same dose of prazosin (10 and 20 mu) was more effective in reducing the clonidine-induced pressor response than central pretreatment with the drug. The pressor response to clonidine (20 micrograms i.c.v.) was not significantly modified by central pretreatment with pyrilamine (50 and 100 micrograms), cimetidine (50 and 100 micrograms), ketanserin (50 and 100 micrograms) or procaine (100 micrograms). The selective alpha-2 adrenoceptor agonist, BHT-920, injected i.c.v. (5-50 micrograms) also produced a dose-dependent pressor response which was abolished by either anesthesia or central pretreatment with yohimbine, but not with prazosin, whereas the selective alpha-1 adrenoceptor agonist, methoxamine (10-100 micrograms i.c.v.), caused a slight increase in mean blood pressure only at higher doses.(ABSTRACT TRUNCATED AT 250 WORDS)
在自由活动的正常血压大鼠中,研究了中枢α2肾上腺素能受体在脑室内注射可乐定所致高血压反应中的可能作用。脑室内注射可乐定(2 - 50微克)可使清醒大鼠产生剂量依赖性且持久的升压反应,并伴有心动过缓,但在麻醉大鼠中则产生持久的降压反应。脑室内预先注射育亨宾(20 - 100微克)可剂量依赖性地拮抗对可乐定(脑室内注射20微克)的升压反应,高剂量(100微克)时可消除该反应,而静脉注射相同剂量的育亨宾对该反应影响较小。脑室内预先注射哌唑嗪(10和20微克)可抑制但不能消除对可乐定的升压反应。然而,静脉注射相同剂量的哌唑嗪(10和20微克)进行全身预先处理比脑室内注射该药物更有效地降低可乐定诱导的升压反应。脑室内预先注射吡苄明(50和100微克)、西咪替丁(50和100微克)、酮色林(50和100微克)或普鲁卡因(100微克)对可乐定(脑室内注射20微克)的升压反应无明显影响。脑室内注射选择性α2肾上腺素能受体激动剂BHT - 920(5 - 50微克)也产生剂量依赖性升压反应,麻醉或脑室内预先注射育亨宾可消除该反应,但预先注射哌唑嗪则不能消除,而选择性α1肾上腺素能受体激动剂甲氧明(脑室内注射10 - 100微克)仅在较高剂量时使平均血压略有升高。(摘要截短于250字)